Literature DB >> 8871418

Family treatment of childhood anxiety: a controlled trial.

P M Barrett1, M R Dadds, R M Rapee.   

Abstract

A family-based treatment for childhood anxiety was evaluated. Children (n = 79) aged 7 to 14 who fulfilled diagnostic criteria for separation anxiety, overanxious disorder, or social phobia were randomly allocated to 3 treatment conditions: cognitive-behavioral therapy (CBT), CBT plus family management (CBT + FAM), and waiting list. The effectiveness of the interventions was evaluated at posttreatment and at 6 and 12 months follow-up. The results indicated that across treatment conditions, 69.8% of the children no longer fulfilled diagnostic criteria for an anxiety disorder, compared with 26% of the waiting-list children. At the 12-month follow-up, 70.3% of the children in the CBT group and 95.6% of the children in the CBT + FAM group did not meet criteria. Comparisons of children receiving CBT with those receiving CBT + FAM on self-report measures and clinician ratings indicated added benefits from CBT + FAM treatment. Age and gender interacted with treatment condition, with younger children and female participants responding better to the CBT + FAM condition.

Entities:  

Mesh:

Year:  1996        PMID: 8871418     DOI: 10.1037//0022-006x.64.2.333

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  137 in total

Review 1.  Evidence-based treatment for mental disorders in children and adolescents.

Authors:  Gregory A Fabiano; William E Pelham
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 2.  Treating childhood shyness and related behavior: empirically evaluated approaches to promote positive social interactions.

Authors:  L A Greco; T L Morris
Journal:  Clin Child Fam Psychol Rev       Date:  2001-12

3.  Development and Preliminary Evaluation of a 1-Week Summer Treatment Program for Separation Anxiety Disorder.

Authors:  Lauren C Santucci; Jill T Ehrenreich; Sarah E Trosper; Shannon M Bennett; Donna B Pincus
Journal:  Cogn Behav Pract       Date:  2009-08-01

4.  Randomized controlled trial: Multimodal Anxiety and Social Skill Intervention for adolescents with autism spectrum disorder.

Authors:  Susan W White; Thomas Ollendick; Anne Marie Albano; Donald Oswald; Cynthia Johnson; Michael A Southam-Gerow; Inyoung Kim; Lawrence Scahill
Journal:  J Autism Dev Disord       Date:  2013-02

Review 5.  Emotion regulation in youth with emotional disorders: implications for a unified treatment approach.

Authors:  Sarah E Trosper; Brian A Buzzella; Shannon M Bennett; Jill T Ehrenreich
Journal:  Clin Child Fam Psychol Rev       Date:  2009-09

Review 6.  Cognitive change and enhanced coping: missing mediational links in cognitive behavior therapy with anxiety-disordered children.

Authors:  Pier J Prins; Thomas H Ollendick
Journal:  Clin Child Fam Psychol Rev       Date:  2003-06

Review 7.  Treatment and Prevention of Depression and Anxiety in Youth: Test of Cross-Over Effects.

Authors:  Judy Garber; Steven M Brunwasser; Argero A Zerr; Karen T G Schwartz; Karen Sova; V Robin Weersing
Journal:  Depress Anxiety       Date:  2016-10       Impact factor: 6.505

8.  Trajectories of change in youth anxiety during cognitive-behavior therapy.

Authors:  Tara S Peris; Scott N Compton; Philip C Kendall; Boris Birmaher; Joel Sherrill; John March; Elizabeth Gosch; Golda Ginsburg; Moira Rynn; James T McCracken; Courtney P Keeton; Dara Sakolsky; Cynthia Suveg; Sasha Aschenbrand; Daniel Almirall; Satish Iyengar; John T Walkup; Anne Marie Albano; John Piacentini
Journal:  J Consult Clin Psychol       Date:  2014-12-08

9.  Disorder-specific effects of CBT for anxious and depressed youth: a meta-analysis of candidate mediators of change.

Authors:  Brian C Chu; Tara L Harrison
Journal:  Clin Child Fam Psychol Rev       Date:  2007-12

Review 10.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.